High On-treatment Platelet Reactivity Identified by Multiple Platelet Function Assay
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
High on-treatment platelet reactivity to adenosine diphosphate was a important reason to
cause ischemic events in antiplatelet therapy. Using single testing to definite HPR may miss
the "true HPR" or over estimate HPR, which may lead to randomized trials failed. It is not
known whether combined multiple platelet function testing could assist to ensure"ture"HPR and
improve clinical outcomes.